CIK 0001326706 · Non-accelerated filer<br>Smaller reporting company
ENvue Medical, Inc.
Sign in to watch- Ticker
- FEED
- Exchange
- OTC
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (914) 233-3004
- Business address
- 969 PRUITT AVE,, TYLER, TX, 77569
- Former names
- NanoVibronix, Inc., Nano Vibronix, Inc., Nano Vibronix Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-30 | FASHEK CHRISTOPHER M Director | Grant or award · Option to Purchase Common Stock | +50,000 | 50,000 | ||
| 2024-12-30 | Cassirer Aurora Director | Grant or award · Option to Purchase Common Stock | +20,000 | 20,000 | ||
| 2024-01-23 | MIKA THOMAS Director | Grant or award · Option to Purchase Common Stock | +16,666 | 16,666 | ||
| 2024-01-23 | JACOB HAROLD Chief Medical Officer | Grant or award · Option to Purchase Common Stock | +6,667 | 6,667 | ||
| 2024-01-23 | Schroeder Maria Director | Grant or award · Option to Purchase Common Stock | +16,667 | 16,667 | ||
| 2024-01-23 | Ferguson Michael Director | Grant or award · Option to Purchase Common Stock | +16,666 | 16,666 | ||
| 2024-01-23 | Goldstein Martin M Director | Grant or award · Option to Purchase Common Stock | +16,667 | 16,667 | ||
| 2024-01-23 | Cassirer Aurora Director | Grant or award · Option to Purchase Common Stock | +16,667 | 16,667 | ||
| 2023-11-29 | Murphy Brian M Chief Executive Officer | Returned to the company · Option to Purchase Common Stock | −1,875 | 0 | ||
| 2023-11-29 | Murphy Brian M Chief Executive Officer | Returned to the company · Option to Purchase Common Stock | −2,500 | 0 | ||
| 2023-11-29 | Murphy Brian M Chief Executive Officer | Returned to the company · Option to Purchase Common Stock | −10,000 | 0 | ||
| 2023-11-29 | Murphy Brian M Chief Executive Officer | Returned to the company · Option to Purchase Common Stock | −15,000 | 0 | ||
| 2023-11-29 | FASHEK CHRISTOPHER M Director | Returned to the company · Options to Purchase Common Stock | −1,125 | 0 | ||
| 2023-11-29 | FASHEK CHRISTOPHER M Director | Returned to the company · Options to Purchase Common Stock | −2,100 | 0 | ||
| 2023-11-29 | FASHEK CHRISTOPHER M Director | Returned to the company · Options to Purchase Common Stock | −2,500 | 0 | ||
| 2023-11-29 | FASHEK CHRISTOPHER M Director | Returned to the company · Options to Purchase Common Stock | −6,000 | 0 | ||
| 2023-11-29 | FASHEK CHRISTOPHER M Director | Returned to the company · Options to Purchase Common Stock | −4,000 | 0 | ||
| 2023-11-29 | Goldstein Martin M Director | Returned to the company · Option to Purchase Common Stock | −4,575 | 0 | ||
| 2023-11-29 | Goldstein Martin M Director | Returned to the company · Option to Purchase Common Stock | −1,125 | 0 | ||
| 2023-11-29 | Goldstein Martin M Director | Returned to the company · Option to Purchase Common Stock | −1,500 | 0 |
Page 3 of 8 · 159 trades